Holen Sie sich die Stockscreener-App
16.16
0.87%
0.14
Vorhandelsmarkt:
16.16
Schlusskurs vom Vortag:
$16.02
Offen:
$16.2
24-Stunden-Volumen:
3.09M
Relative Volume:
1.08
Marktkapitalisierung:
$3.82B
Einnahmen:
$382.81M
Nettoeinkommen (Verlust:
$68.13M
KGV:
57.71
EPS:
0.28
Netto-Cashflow:
$78.82M
1W Leistung:
-0.98%
1M Leistung:
-7.13%
6M Leistung:
+20.96%
1J Leistung:
+222.55%
1-Tages-Spanne:
$15.92
$16.50
1-Wochen-Bereich:
$15.92
$17.32
52-Wochen-Spanne:
$5.00
$23.64
Adma Biologics Inc Stock (ADMA) Company Profile
Firmenname
Adma Biologics Inc
Sektor
Branche
Telefon
(201) 478-5552
Adresse
C/O ADMA BIOLOGICS, INC., RAMSEY
Vergleichen Sie ADMA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
16.16 | 3.82B | 382.81M | 68.13M | 78.82M | 0.28 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-07-19 | Fortgesetzt | Raymond James | Strong Buy |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2021-11-11 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-06-04 | Eingeleitet | Jefferies | Buy |
| 2019-04-15 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-07 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-12-11 | Bestätigt | Maxim Group | Buy |
| 2017-11-14 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | Hochstufung | Maxim Group | Hold → Buy |
| 2016-08-01 | Herabstufung | Maxim Group | Buy → Hold |
| 2016-07-25 | Bestätigt | Maxim Group | Buy |
| 2015-05-13 | Bestätigt | Maxim Group | Buy |
| 2014-12-08 | Eingeleitet | Oppenheimer | Outperform |
| 2014-12-01 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Adma Biologics Inc Aktie (ADMA) Neueste Nachrichten
Perpetual Ltd Invests $62.30 Million in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
ADMA Stock Catapults 275.7% in a Year: How Should You Play the Stock? - MSN
Blood Plasma Market Growing at 4.07% CAGR to Hit 42.0 Billion USD by 2032 | Emergent BioSolutions, ADMA - EIN News
There May Still Be Time to Get in on These 3 Trending Biotechs - MarketBeat
Sana Biotechnology Inc (SANA-Q) QuotePress Release - The Globe and Mail
How the (ADMA) price action is used to our Advantage - Stock Traders Daily
Assenagon Asset Management S.A. Sells 2,882,776 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
ADMA Biologics Inc. (ADMA): Why Should You Buy This Growth Stock For The Next 5 Years? - Insider Monkey
ADMA Biologics, Inc. (NASDAQ:ADMA) Short Interest Update - MarketBeat
ADMA Biologics, Inc. (NASDAQ:ADMA) Shares Sold by JPMorgan Chase & Co. - MarketBeat
Adma Biologics (ADMA) Stock Sinks As Market Gains: Here's Why - MSN
ADMA Biologics (NASDAQ:ADMA) Stock Price Down 8.8%Here's What Happened - MarketBeat
Analysts Issue Forecasts for ADMA Biologics FY2024 Earnings - MarketBeat
ADMA Biologics (NASDAQ:ADMA) Trading Down 8.8%What's Next? - MarketBeat
EWG Elevate Inc. Invests $480,000 in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
ADMA Biologics Announces Preliminary Full Year 2024 Revenue and Provides Business Update - The Manila Times
Adma Biologics (ADMA) Surpasses Market Returns: Some Facts Worth Knowing - MSN
12 Best Growth Stocks Under $25 to Buy Now - Insider Monkey
Is ADMA Biologics, Inc. (ADMA) the Best Growth Stock to Buy Now Under $25? - Insider Monkey
(ADMA) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Is It Worth Investing in Adma Biologics (ADMA) Based on Wall Street's Bullish Views? - MSN
High Growth Tech Stocks to Watch in January 2025 - Yahoo Finance
ADMA Biologics to Participate in the J.P. Morgan Healthcare Conference on January 13, 2025 - The Manila Times
ADMA Biologics, Inc. Appoints Eduardo Rene Salas to Serve on the Board as a Class I Director - Marketscreener.com
Why Is ADMA Biologics, Inc. (ADMA) Among the Best Multibagger Stocks to Buy Right Now? - Insider Monkey
Does ADMA Biologics (NASDAQ:ADMA) Have A Healthy Balance Sheet? - Simply Wall St
12 Best Multibagger Stocks to Buy Right Now - Insider Monkey
Are Medical Stocks Lagging Alvotech (ALVO) This Year? - Yahoo Finance
How Is The Market Feeling About ADMA Biologics? - Benzinga
(ADMA) Investment Analysis and Advice - Stock Traders Daily
ADMA Biologics, A Top 1% Stock, Skyrockets After Settling Its Accounting Debacle - MSN
The Zacks Analyst Blog Highlights ADMA Biologics, Tarsus Pharmaceuticals, Stoke Therapeutics, Inc. and ChromaDex - Yahoo Finance
4 Drug, Biotech Stocks Rising More Than 50% in 2024 With Room to Grow - Yahoo Finance
Tidal Investments LLC Trims Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
ADMA Biologics (NASDAQ:ADMA) Shares Gap DownShould You Sell? - MarketBeat
ADMA Biologics, Inc. Announces Partial Paydown of Senior Term Loan Credit Facility - Marketscreener.com
ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility - The Manila Times
The Zacks Analyst Blog Highlights Sarepta Therapeutics, ADMA Biologics, Exelixis and Alnylam - Yahoo Finance
Teachers Retirement System of The State of Kentucky Acquires New Stake in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Geode Capital Management LLC Boosts Stock Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Wellington Management Group LLP Has $2.39 Million Stake in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
ADMA Biologics shares target lifted on strong product momentum By Investing.com - Investing.com Canada
Barclays PLC Acquires 347,692 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
ADMA Biologics shares target lifted on strong product momentum - Investing.com
Finanzdaten der Adma Biologics Inc-Aktie (ADMA)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):